Search Within

METABOLIC DISORDERS
Emerging Drugs and Indications for Cardio-Metabolic Disorders in People with Severe Mental Illness

Journal: Current Pharmaceutical Design
Volume: 21,Issue: 23
Page: 3317-3324
Authors: Youssef Kouidrat, Ali Amad and Marc De Hert

Intra-uterine Growth Retardation as a Risk Factor of Postnatal Metabolic Disorders

Journal: Current Pharmaceutical Biotechnology
Volume: 17,Issue: 7
Page: 587-596
Authors: Radzislaw Mierzynski, Dominik Dluski, Dorota Darmochwal-Kolarz, Elzbieta Poniedziałek-Czajkowska, Bozena Leszczynska-Gorzelak, Zaneta Kimber-Trojnar, Agnieszka-Wankowicz and Jan Oleszczuk

FoxO1 Inhibitors: The Future Medicine for Metabolic Disorders?

Journal: Current Diabetes Reviews
Volume: 12,Issue: 3
Page: 223-230
Authors: Anuradha Pandey, Goru Santosh Kumar, Almesh Kadakol, Vajir Malek and Anil Bhanudas Gaikwad

Therapeutic Development of Interrelated Metabolic and Neurodegenerative Disorders

Journal: Current Pharmaceutical Design
Volume: 22,Issue: 23
Page: 3608-3618
Authors: Xuan Thi-Anh Nguyen and Ly Le

Emerging Potential of Natural Products as an Alternative Strategy to Pharmacological Agents Used Against Metabolic Disorders

Journal: Current Drug Metabolism
Volume: 17,Issue: 6
Page: 582-597
Authors: Tânia R. Dias, Raquel L. Bernardino, Maria J. Meneses, Mário Sousa, Rosália Sá, Marco G. Alves, Branca M. Silva and Pedro F. Oliveira

Brain Aging and Disorders of the Central Nervous System: Kynurenines and Drug Metabolism

Journal: Current Drug Metabolism
Volume: 17,Issue: 5
Page: 412-429
Authors: Nóra Török, Zsófia Majláth, Ferenc Fülöp, József Toldi and László Vécsei

Interrelationship Between Periapical Lesion and Systemic Metabolic Disorders

Journal: Current Pharmaceutical Design
Volume: 22,Issue: 15
Page: 2204-2215
Authors: Hajime Sasaki, Kimito Hirai, Christine M. Martins, Hisako Furusho, Ricardo Battaglino and Koshi Hashimoto

Berberine: New Insights from Pharmacological Aspects to Clinical Evidences in the Management of Metabolic Disorders

Journal: Current Medicinal Chemistry
Volume: 23,Issue: 14
Page: 1460-1476
Authors: Cristiana Caliceti, Placido Franco, Silvia Spinozzi, Aldo Roda and Arrigo F.G. Cicero


Discovery of Novel Anti-Diabetic Drugs by Targeting Lipid Metabolism

Journal: Current Drug Targets
Volume: 16,Issue: 12
Page: 1372-1380
Authors: Xiu Zhou, Jun Xu, Yuguang Shi and Ji-Ming Ye

Visceral Adiposity Measurements, Metabolic and Inflammatory Profi le in Obese Patients with and Without Type 2 Diabetes Mellitus: A Crosssectional Analysis

Journal: Current Diabetes Reviews
Volume: 13,Issue: 1
Page: 11-18
Authors: Denise Rosso Tenório Wanderley Rocha, André Rocha Jorge, Valeria Bender Braulio, Alberto Krayyem Arbex and Aline Marcadenti

18F-FDG-PET Correlates of Impulse Control Disorder in a Diabetic Patient

Journal: Endocrine, Metabolic & Immune Disorders-Drug Targets
Volume: 16,Issue: 3
Page: 224-227
Authors: Burak Yulug, Lütfü Hanoglu, Ahmet Mithat Tavlı, Tansel Cakir, Elmir Khanmammadov and Oktay Olmuscelik

Interrelationships with Metabolic Syndrome, Obesity and Cardiovascular Risk

Journal: Current Vascular Pharmacology
Volume: 14,Issue: 5
Page: 415-425
Authors: Sarmad Said, Debabrata Mukherjee and Thomas F. Whayne

Role of Mitochondria and Other ROS Sources in Hyperthyroidism-Linked Oxidative Stress

Journal: Immunology‚ Endocrine & Metabolic Agents in Medicinal Chemistry
Volume: 15,Issue: 1
Page: 5-36
Authors: Paola Venditti, Gaetana Napolitano and Sergio Di Meo

Therapeutic Approaches Using Riboflavin in Mitochondrial Energy Metabolism Disorders

Journal: Current Drug Targets
Volume: 17,Issue: 13
Page: 1527-1534
Authors: Bárbara J. Henriques, Tânia G. Lucas and Cláudio M. Gomes

Previous     Next

Go To   Results 1 - 15 of 2665